IL26 and rheumatoid arthritis: Taken together, our findings show the molecular mechanisms of IL-26 involved in macrophage subtype regulation of the innate immune system and might make IL-26 a potential therapeutic target for M1-dominant autoimmune or inflammatory diseases such as RA.